meglumine antimoniate has been researched along with chitosan in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrió, J; García, E; Miñarro, M; Pérez, P; Portus, M; Pujals, G; Suñé-Negre, JM; Tico, JR | 1 |
| Barbosa, H; Delgado, G; Gutiérrez, J; Pinzón, J; Vallejo, B | 1 |
| Ahmadi, F; Bahrami, S; Esmaeilzadeh, S; Zarei, M | 1 |
| Akhtar, S; Ashraf, S; Hussain, I; Hussain, SZ; Rafay, M; Sarwar, HS; Shahnaz, G; Sohail, MF; Yasinzai, M | 1 |
4 other study(ies) available for meglumine antimoniate and chitosan
| Article | Year |
|---|---|
In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum.
Topics: Animals; Antimony; Antiprotozoal Agents; Cells, Cultured; Chitosan; Female; Inhibitory Concentration 50; Leishmania infantum; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Microspheres; Organometallic Compounds; Parasitic Sensitivity Tests | 2008 |
In vitro analysis regarding the safety of components used in a film-based therapeutic system loaded with meglumine antimoniate and its activity toward Leishmania major experimental infections: a preliminary study.
Topics: Antiprotozoal Agents; Cell Line; Cell Survival; Chitosan; Cicatrix; Drug Carriers; Excipients; Fibroblasts; Humans; Immunomodulation; Interleukins; Lactic Acid; Leishmania major; Leishmaniasis, Cutaneous; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pilot Projects; Povidone; Wound Healing | 2013 |
Potential application of nanochitosan film as a therapeutic agent against cutaneous leishmaniasis caused by L. major.
Topics: Animals; Antiprotozoal Agents; Chitosan; Female; Leishmania major; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Treatment Outcome | 2015 |
Mannosylated thiolated polyethylenimine nanoparticles for the enhanced efficacy of antimonial drug against Leishmaniasis.
Topics: Antiprotozoal Agents; Biological Transport; Chitosan; Drug Carriers; Drug Liberation; Humans; Leishmania; Leishmaniasis; Mannose; Meglumine; Meglumine Antimoniate; Nanoparticles; Organometallic Compounds; Particle Size; Polyethyleneimine; Sulfhydryl Compounds; Surface Properties | 2018 |